Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants
| Description | Thalidomide BMS 50mg capsules (Bristol-Myers Squibb Pharmaceuticals Ltd) |
| BNF code | 0802040AABBAAAA |
| Virtual Medicinal Product | Thalidomide 50mg capsules |
| Name | Thalidomide BMS 50mg capsules |
| Date of name applicability | 1 Nov 2022 |
| Previous name | Thalidomide Celgene 50mg capsules |
| Supplier | Bristol-Myers Squibb Pharmaceuticals Ltd |
| Current licensing authority | Medicines - MHRA/EMA |
| EMA additional monitoring | ✗ |
| Parallel import | ✗ |
| Restrictions on availability | None |
| Licensed Route | |
|---|---|
| Licenced route | Oral |
| Actual Medicinal Product Packs | |
| Thalidomide BMS 50mg capsules (Bristol-Myers Squibb Pharmaceuticals Ltd) 28 capsule 2 x 14 capsules | |
dm+d data retrieved from TRUD: release NHSBSA_2.0.0_20260202000001, imported on 3rd February 2026 at 04:14:48.